InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,283.40
(
0.11%
)
US TECH 100
18,075.20
(
-0.28%
)
Dow Jones
38,571.03
(
0.00%
)
Brent Oil
77.19
(
-1.22%
)
Bitcoin
68,905.64
(
0.15%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

micanwait

Send PM Follow Ignore
Followers 6
Posts 718
Boards Moderated 0
Alias Born 06/22/2011

micanwait

Re: None

Wednesday, 03/05/2014 7:27:02 AM

Wednesday, March 05, 2014 7:27:02 AM

Post# of 80490
"Moving forward in Japan and in other markets lifting of clinical holds on a trial-by-trial basis will be ultimate goal of moving to the earlier lines of treatment moving to a substantial entry into the second line and ultimately to first line based upon strengthening the benefit risk of Iclusig and new clinical data that we’ll be generating and the medical community at large will be generating." HB

The clarity of this statement is impressive. Would HB have said this with such certainty if he was not extremely confident of financing?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up